Upper Gastrointestinal Stent Insertion in Malignant and Benign Disorders.

Author: Hyoun Woo KANG ¹ ; Sang Gyun KIM
Author Information

1. Department of Internal Medicine, Dongguk University Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
Publication Type:Review
Keywords: Upper gastrointestinal tract; Stents; Obstruction; Malignant; Benign
MeSH: Constriction, Pathologic; Esophageal Neoplasms; Esophagus; Palliative Care; Plastics; Stents*; Upper Gastrointestinal Tract
From:Clinical Endoscopy 2015;48(3):187-193
CountryRepublic of Korea
Language:English
Abstract: Upper gastrointestinal (GI) stents are increasingly being used to manage upper GI obstructions. Initially developed for palliative treatment of esophageal cancer, upper GI stents now play an emerging role in benign strictures of the upper GI tract. Because recurrent obstruction and stent-related complications are common, new modifications of stents have been implemented. Self-expandable metal stents (SEMS) have replaced older plastic stents. In addition, newly designed SEMS have been developed to prevent complications. This review provides an overview of the various types, indications, methods, complications, and clinical outcomes of upper GI stents in a number of malignant and benign disorders dividing the esophagus and gastroduodenum.